The World Health Organization (WHO) announced on June 25 local time that after a meeting of its emergency committee, the World Health Organization (WHO) decided that the monkeypox outbreak did not constitute a "public health emergency of international concern" at this stage, Zhitong Financial APP learned.

It is reported that World Health Organization (WHO) shared data on the current monkeypox epidemic at an emergency committee meeting on June 23, stressing that more than 47 countries have reported 3040 monkeypox cases since the beginning of May.

The Committee agreed that the monkeypox outbreak did not constitute a "public health emergency of international concern" at this stage, but pointed out that the epidemic needed to be controlled to prevent its further spread and that the epidemic should be closely monitored. In addition, the Committee recommends that the monkeypox outbreak be assessed again in a few weeks' time.

Monkeypox concept stocks in US stocks include monkeypox vaccine developers Emergent BioSolution (EBS.US), Chimerix (CMRX.US), monkeypox therapy developers SIGA Technologies (SIGA.US), Tonix Pharmaceuticals (TNXP.US), GeoVax Labs (GOVX.US), and monkeypox virus testing products manufacturers Co-Diagnostics (CODX.US), Abbott Laboratories (ABT.US), and RHHBY.US.